Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Milrinone for persistent pulmonary hypertension of the newborn
ISRCTN12949496Phase 3Terminated
- Sponsor
- RCSI University of Medicine and Health Sciences
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in persistent pulmonary hypertension of the newborn (PPHN) comparing Milrinone arm with Placebo arm (2 arms). Primary endpoints: Time on inhaled nitric oxide therapy and Time spent on invasive ventilation. Started Nov 2015; status: terminated.
02
Drugs
milrinone
03
Conditions
persistent pulmonary hypertension of the newborn (PPHN)
Beyond the preview
Go deeper on ISRCTN12949496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN12949496.